Navigation Links
Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO)
Date:12/8/2008

SAN FRANCISCO, Dec. 8 /PRNewswire/ -- Quantros, a leading provider of safety, quality, and compliance solutions for the healthcare industry, today announced that the Agency for Healthcare Research and Quality (AHRQ) has granted initial certification to Quantros Patient Safety Center as a Patient Safety Organization (PSO). The listing can be viewed at http://www.pso.ahrq.gov/listing/psolist.htm. The Quantros Patient Safety Center is a new division within Quantros that is specifically focused on review of safety processes, data analytics, and provision of associated knowledge content and complementary services to support healthcare providers using Quantros as a PSO to better address patient safety. Supporting healthcare providers in the improvement of safety and quality initiatives is in complete alignment with the mission and goals of the organization for more than nine years. Today more than 2,000 healthcare providers use one or more Quantros solutions for improving safety and quality within their care environment.

In addition to the Quantros Patient Safety Center, Quantros also supports other entities acting as a PSO with Quantros Patient Safety Organization (PSO) Manager, a streamlined, Web-based application that will enable PSOs to seamlessly aggregate required Common Format (CM) for event data as well as additional safety data for use as a confidential Patient Safety Work Product (PSWP). Just as with The Joint Commission ORYX Core Measures program, Quantros has chosen to act as both a technology provider and a PSO.

Dr. Sanjaya Kumar, Quantros President and CEO commented, "Quantros is in business to assist healthcare providers in advancing safety and quality improvement initiatives. The Quantros Patient Safety Center was created to further that cause for healthcare providers who want to leverage both Quantros and associated partner expertise. In addition, PSO vendors utilizing Quantros PSO Manager can avail of the services and content infrastructure and make that available to their members."

The Quantros Patient Safety Center will provide complete support per the PSO regulations including the aggregation, protection and dissemination of information including submissions and comparative reports via the Network of Patient Safety Databases (NPSD) as well as the aggregated, PHI de-identified Quantros Patient Safety Center data repository. This new division will provide a host of clinically-based services and analysis specifically designed for improving safety within the healthcare environment.

Additional information concerning the Quantros Patient Safety Center can be viewed at http://www.quantros.com/qpsc.

About Quantros

Quantros provides real-time solutions for safety and risk management, outcomes and performance monitoring, accreditation and compliance, and surveillance and decision support for leading healthcare providers throughout the nation. Quantros' web delivered applications provide a standard platform that creates actionable knowledge that helps its clients save lives, improve quality, and conserve assets. Through a variety of direct sales and vendor partners, more than 2,000 healthcare facilities use Quantros' web-based technology solutions every day.

Quantros team members include physicians, nurses and healthcare professionals as well as an experienced team of information technology specialists. Visit Quantros on the web at http://www.quantros.com.


'/>"/>
SOURCE Quantros
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
2. Quantros Expanding Support for Alternative Web Browsers
3. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
4. Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial
5. Electronic Prescribing Saves Patients Money
6. Confusing risk information may lead breast cancer patients to make poor treatment choices
7. Marital problems lead to poorer outcomes for breast cancer patients
8. Vitamin B1 could reverse early-stage kidney disease in diabetes patients
9. Lenalidomide safe as single therapy for elderly CLL patients
10. Dieticians & Nutritionists Concerned Economic Downturn Will Effect Patient Health and Diets.
11. CHOC Childrens Draws First Patient Dose With RIVA System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: